We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SITC:NYSESITE Centers Corp. Analysis

Data as of 2026-05-01 - not real-time

$5.49

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

SITE Centers trades at $5.49, just above its 20‑day SMA of $5.44 but well below the 50‑day ($5.72) and 200‑day ($7.69) averages, indicating short‑term momentum but a longer‑term bearish backdrop. The MACD shows a bullish signal as the line ($‑0.032) sits above the signal ($‑0.066) and the histogram is positive, while the RSI at 48 suggests the stock is neither overbought nor oversold. Volume is on a decreasing trend, and 30‑day volatility is high at ~23%, with a historic max drawdown of nearly 60%, underscoring elevated price swings. Upcoming Q1 2026 earnings on May 7 and a recent Piper Sandler price‑target lift (maintaining a neutral stance) are the primary news catalysts that could sway sentiment in the near term. Fundamentally, the REIT appears dramatically cheap: a trailing P/E of 1.63 versus an industry average of 33.9, a price‑to‑book of 0.86 and a DCF‑derived fair value of $13.84 suggest substantial upside, though revenue has contracted 45.7% and operating margins are negative. The balance sheet is modestly leveraged (debt‑to‑equity ~10) with solid cash generation (free cash flow $48.3 M) and a striking ROE of 41.8%, but the lack of dividend payout removes a traditional REIT income appeal. Overall, the stock sits at a crossroads between technical weakness and compelling valuation upside.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price hovering near short‑term resistance at $5.63
  • Bearish longer‑term SMA alignment and decreasing volume
  • High short‑term volatility and upcoming earnings release

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation gap (DCF fair value $13.84 vs market $5.49)
  • Strong cash generation and low price‑to‑book
  • P/E compression far below industry norm

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Sustained undervaluation despite sector headwinds
  • Robust ROE and manageable leverage
  • Potential upside from strategic repositioning of retail assets

Key Metrics & Analysis

Financial Health

Revenue Growth-45.70%
Profit Margin144.68%
P/E Ratio1.6
ROE41.77%
ROA-0.21%
Debt/Equity10.26
P/B Ratio0.9
Op. Cash Flow$19.6M
Free Cash Flow$48.3M
Industry P/E33.9

Technical Analysis

TrendBearish
RSI48.2
Support$5.24
Resistance$5.63
MA 20$5.44
MA 50$5.72
MA 200$7.69
MACDBullish
VolumeDecreasing
Fear & Greed Index90.91

Valuation

Fair Value$13.84
Target Price$6.00
Upside/Downside9.29%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.04
Volatility23.09%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.